Company intelligence / Profile preview
Mymetics Corporation
Lausanne, Vaud, Switzerlandmymetics.com ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Other
01
Overview
Mymetics has developed a proprietary virosome-based vaccine platform with several candidates targeting infectious diseases. Clinical results have shown promise, particularly for intranasal influenza and HIV vaccines. The company has secured significant partnerships and non-dilutive funding from organizations like Astellas, Gates Foundation, and PATH-MVI. Its RSV vaccine candidate was outlicensed to Astellas with up to $82 million in potential payments plus royalties. The malaria candidate received support from PATH-MVI; the HIV program received Gates Foundation funding for studies at Texas Biomedical Research Institute.[2]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Virosome-based vaccines
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Astellas Pharma / RSV Corp – Out-license/collaboration on RSV virosomal vaccines ($82M deal + royalties)[2][4]Gates Foundation – Funding for HIV research/studies at Texas Biomedical Research Institute[2]PATH-MVI – Funding/support for malaria transmission-blocking candidate development [2]
Beyond the preview
Go deeper on Mymetics Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mymetics Corporation.